pemvidutide
Altimmune’s Incretin Misses Fibrosis Improvement Endpoints in MASH Trial
Altimmune; incretin; pemvidutide; fibrosis; MASH; GLP-1; clinical trial
Actionable Insights Powered by AI
Altimmune; incretin; pemvidutide; fibrosis; MASH; GLP-1; clinical trial